Ueda, Norihiro
Zhang, Rong
Tatsumi, Minako
Liu, Tian-Yi
Kitayama, Shuichi
Yasui, Yutaka
Sugai, Shiori
Iwama, Tatsuaki
Senju, Satoru
Okada, Seiji
Nakatsura, Tetsuya
Kuzushima, Kiyotaka
Kiyoi, Hitoshi
Naoe, Tomoki
Kaneko, Shin
Uemura, Yasushi
Article History
Received: 3 September 2015
Revised: 22 January 2016
Accepted: 24 January 2016
First Online: 15 May 2016
Competing interests
: Shin Kaneko is a founder, shareholder and scientific adviser at AsTlym Co., Ltd. Hitoshi Kiyoi received research funding from Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Zenyaku Kogyo and Fujifilm Corporation. The remaining authors declare no conflict of interest.